EQUILLIUM, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.67 USD | +7.05% |
|
-2.34% | +130.98% |
Chart calendar Equillium, Inc.
40dd640be2dc8.zDeySYA1teEeqrYW3DSuCDhaVy6PBg2BgkYbAmN8Qwk.qAHmP_ZsjbZz-vN_kkbYZW0wZlS_Ql2w0iIqNQEYDkL1RNMcyUSMu3v72Q~90be68969a2105943398060289201ae4
Upcoming events on Equillium, Inc.
Past events on Equillium, Inc.
| 09/04/2024 07:00 pm | LD Micro Invitational Conference |
| 28/03/2024 11:30 pm | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference - Fireside Chat |
| 26/03/2024 01:31 am | Q4 2023 Earnings Release |
| 13/11/2023 07:30 pm | American College of Rheumatology Conference - Abstract Number: 1496 |
| 09/11/2023 02:31 am | Q3 2023 Earnings Release |
| 04/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Poster Number: SA-PO875 |
| 16/10/2023 10:00 pm | Peptide Therapeutics Symposium |
| 16/10/2023 09:30 pm | Investor Day |
| 09/10/2023 | JonesTrading Healthcare Summit - Panel |
| 03/10/2023 11:30 pm | LD Micro Main Event Conference |
| 27/09/2023 05:30 pm | Cantor Global Healthcare Conference |
| 12/09/2023 08:00 pm | H.C. Wainwright Global Investment Conference |
| 06/09/2023 | Wells Fargo Healthcare Conference |
| 10/08/2023 01:31 am | Q2 2023 Earnings Release |
| 09/06/2023 08:00 pm | Jefferies Global Healthcare Conference |
| 08/06/2023 12:00 am | LD Micro Invitational Conference |
| 22/05/2023 09:30 pm | Annual General Meeting |
| 12/05/2023 01:31 am | Q1 2023 Earnings Release |
| 11/05/2023 | American Association of Immunologists Meeting - Poster Number: P854 |
| 23/04/2023 | European Society for Blood and Marrow Transplantation Meeting - Poster Number: P322 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 15,8 10,4 51.53% | 36,1 32,8 9.96% | 42,5 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -26,7 -25,9 -3.09% | -29,5 -28,5 -3.76% | -37,8 -37,8 -0.03% | -62,1 -56,0 -10.92% | -14,5 -18,0 19.26% | -6,43 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,6 -24,4 -5.02% | -29,8 -29,7 -0.33% | -39,1 -38,9 -0.48% | -62,4 -58,1 -7.45% | -12,8 -17,3 26.23% | -5,47 |
|
Net income Million USD | Released Forecast Spread | -25,6 -24,8 -3.28% | -29,8 -29,7 -0.33% | -39,1 -39,0 -0.24% | -62,4 -62,2 -0.43% | -13,3 -16,9 21.11% | -1,12 |
|
EPS USD | Released Forecast Spread | -1,47 -1,42 -3.34% | -1,46 -1,52 4.11% | -1,36 -1,31 -4.13% | -1,85 -1,85 0.11% | -0,38 -0,48 20.83% | -0,04 |
| Announcement Date | 26/03/20 | 24/03/21 | 23/03/22 | 23/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 15,8 10,4 51.53% | 8,88 6,74 31.81% | 9,12 6,14 48.6% | 8,87 4,75 86.74% | 9,21 5,90 56.12% | 6,83 | 6,48 | 24,9 | 4,30 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,4 -10,2 -1.58% | -37,3 -11,1 -235.29% | -13,6 -14,0 2.97% | -13,2 -12,2 -8.5% | 2,04 -1,57 230.34% | -4,11 -6,01 31.7% | -3,59 -5,18 30.61% | -3,62 -6,07 40.28% | -3,20 -6,83 53.11% | -5,13 | -4,60 | 12,4 | -8,77 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,6 -10,4 -2.3% | -37,4 -11,3 -231.51% | -14,1 -14,2 0.21% | -13,7 -12,7 -7.7% | 2,77 -1,57 277% | -3,88 -6,20 37.47% | -3,34 -5,39 38.15% | -3,21 -5,62 42.78% | -2,33 -6,58 64.62% | -5,00 | -4,38 | 12,7 | -8,47 | |
|
Net income Million USD | Released Forecast Spread | -10,6 -10,5 -1.27% | -37,4 -11,3 -230.83% | -14,1 -14,2 0.21% | -13,7 -13,1 -4.45% | 2,77 1,77 56.93% | -3,94 -5,97 33.95% | -3,34 -5,53 39.52% | -3,71 -5,52 32.73% | -2,34 -6,10 61.59% | -5,04 | -4,60 | 14,7 | -6,10 | |
|
EPS USD | Released Forecast Spread | -0,37 -0,32 -16.35% | -1,17 -0,37 -214.09% | -0,41 -0,42 1.2% | -0,40 -0,36 -11.11% | 0,08 0,08 -3.03% | -0,11 -0,18 38.2% | -0,10 -0,16 37.5% | -0,11 -0,16 32.31% | -0,06 -0,17 64.71% | -0,15 | -0,13 | 0,42 | -0,18 | -0,20 |
| Announcement Date | 23/03/22 | 12/05/22 | 15/08/22 | 14/11/22 | 23/03/23 | 11/05/23 | 09/08/23 | 08/11/23 | 25/03/24 | - | - | - | - | - |
More events
Past sector events for Equillium, Inc.
| 03/05/2024 04:37 pm | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 03:30 pm | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 01:31 am | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:13 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 02/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EQ Stock
- Calendar Equillium, Inc.
